Citation Impact
Citing Papers
Cancer immunotherapies targeting the PD-1 signaling pathway
2017 StandoutNobel
Lupus‐like cutaneous reaction following pembrolizumab: An immune‐related adverse event associated with anti‐PD‐1 therapy
2017
Delivering safer immunotherapies for cancer
2017
Enhancing extracellular vesicle cargo loading and functional delivery by engineering protein-lipid interactions
2024 StandoutNobel
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
2019 Standout
Chronic inflammation in the etiology of disease across the life span
2019 Standout
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning
2018 Standout
Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor
2016
Dermatologic Reactions to Immune Checkpoint Inhibitors
2017
Psoriasis
2021 Standout
Psoriasis: Which therapy for which patient
2018
Delivery technologies for cancer immunotherapy
2019 Standout
Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
2017 Standout
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Association between light at night, melatonin secretion, sleep deprivation, and the internal clock: Health impacts and mechanisms of circadian disruption
2017
Diagnosis, monitoring and management of immune-related adverse drug reactions of anti-PD-1 antibody therapy
2016
Role of PD-1 in Immunity and Diseases
2017 StandoutNobel
PD-1/PD-L1 blockade in cancer treatment: perspectives and issues
2016
Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic Viral Infections and Cancer
2017 StandoutNobel
Hidradenitis suppurativa
2020 Standout
Pre-existing pulmonary fibrosis is a risk factor for anti-PD-1-related pneumonitis in patients with non-small cell lung cancer: A retrospective analysis
2018
The PI3K Pathway in Human Disease
2017 Standout
Psoriasis
2016
Molecular characterization of pulmonary sarcomatoid carcinoma: analysis of 33 cases
2016
Characterization of dermatitis after PD-1/PD-L1 inhibitor therapy and association with multiple oncologic outcomes: A retrospective case-control study
2018
Inhalable particulate drug delivery systems for lung cancer therapy: Nanoparticles, microparticles, nanocomposites and nanoaggregates
2017
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
Obesity and Cancer Mechanisms: Cancer Metabolism
2016
Atomically Precise Colloidal Metal Nanoclusters and Nanoparticles: Fundamentals and Opportunities
2016 Standout
Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance
2020
Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems
2018 Standout
Association of Immune-Related Adverse Events With Nivolumab Efficacy in Non–Small-Cell Lung Cancer
2017
Dermatologic complications of anti-PD-1/PD-L1 immune checkpoint antibodies
2016
Clinical and Histologic Features of Lichenoid Mucocutaneous Eruptions Due to Anti–Programmed Cell Death 1 and Anti–Programmed Cell Death Ligand 1 Immunotherapy
2016
Protein Lipidation: Occurrence, Mechanisms, Biological Functions, and Enabling Technologies
2018
Designed Modular Proteins as Scaffolds To Stabilize Fluorescent Nanoclusters
2015
Plk1 Inhibitors in Cancer Therapy: From Laboratory to Clinics
2016
Molecular Pathways: Immune Checkpoint Antibodies and their Toxicities
2016
Hidradenitis Suppurativa
2017
Regulatory T cells expressing abundant CTLA‐4 on the cell surface with a proliferative gene profile are key features of human head and neck cancer
2018 StandoutNobel
Works of Igor Vujic being referenced
The infliximab biosimilar in the treatment of moderate to severe plaque psoriasis
2016
Combined Inhibition of MEK and Plk1 Has Synergistic Antitumor Activity in NRAS Mutant Melanoma
2015
Low-dose inhalation of interleukin-2 bio-chemotherapy for the treatment of pulmonary metastases in melanoma patients
2014
The role of wide local excision for the treatment of severe hidradenitis suppurativa (Hurley grade III): Retrospective analysis of 74 patients
2017
Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression
2015
Metformin and trametinib have synergistic effects on cell viability and tumor growth inNRASmutant cancer
2014
Acyl protein thioesterase 1 and 2 (APT-1, APT-2) inhibitors palmostatin B, ML348 and ML349 have different effects on NRAS mutant melanoma cells
2016
DNA and aptamer stabilized gold nanoparticles for targeted delivery of anticancer therapeutics
2014
The Risk of Melanoma in Airline Pilots and Cabin Crew
2014
Apremilast in psoriasis – a prospective real‐world study
2017